1. Home
  2. GRFS vs OLED Comparison

GRFS vs OLED Comparison

Compare GRFS & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • OLED
  • Stock Information
  • Founded
  • GRFS 1940
  • OLED 1985
  • Country
  • GRFS Spain
  • OLED United States
  • Employees
  • GRFS N/A
  • OLED N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • OLED Semiconductors
  • Sector
  • GRFS Health Care
  • OLED Technology
  • Exchange
  • GRFS Nasdaq
  • OLED Nasdaq
  • Market Cap
  • GRFS 6.2B
  • OLED 7.4B
  • IPO Year
  • GRFS 2006
  • OLED 1992
  • Fundamental
  • Price
  • GRFS $10.10
  • OLED $149.21
  • Analyst Decision
  • GRFS Hold
  • OLED Strong Buy
  • Analyst Count
  • GRFS 1
  • OLED 7
  • Target Price
  • GRFS $10.30
  • OLED $190.43
  • AVG Volume (30 Days)
  • GRFS 1.1M
  • OLED 427.7K
  • Earning Date
  • GRFS 01-01-0001
  • OLED 07-31-2025
  • Dividend Yield
  • GRFS N/A
  • OLED 1.21%
  • EPS Growth
  • GRFS N/A
  • OLED 4.58
  • EPS
  • GRFS 0.31
  • OLED 4.81
  • Revenue
  • GRFS $7,968,532,207.00
  • OLED $648,702,000.00
  • Revenue This Year
  • GRFS $7.14
  • OLED $5.77
  • Revenue Next Year
  • GRFS $7.16
  • OLED $11.73
  • P/E Ratio
  • GRFS $41.40
  • OLED $31.02
  • Revenue Growth
  • GRFS 10.76
  • OLED 6.13
  • 52 Week Low
  • GRFS $6.19
  • OLED $103.70
  • 52 Week High
  • GRFS $10.30
  • OLED $231.83
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 67.23
  • OLED 41.82
  • Support Level
  • GRFS $9.66
  • OLED $148.19
  • Resistance Level
  • GRFS $10.30
  • OLED $153.17
  • Average True Range (ATR)
  • GRFS 0.26
  • OLED 3.34
  • MACD
  • GRFS 0.00
  • OLED -0.88
  • Stochastic Oscillator
  • GRFS 85.19
  • OLED 7.40

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: